Market Value1,013,563,000
Total Holdings89
File Date2022-05-13
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
NKTR / Nektar Therapeutics
SILK / Silk Road Medical, Inc
BDX / Becton, Dickinson and Company
VRTX / Vertex Pharmaceuticals Incorporated
DCPH / Deciphera Pharmaceuticals, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
ZBH / Zimmer Biomet Holdings, Inc.
SWAV / Shockwave Medical, Inc.
MYOV / Myovant Sciences Ltd
ELV / Elevance Health, Inc.
BHVN / Biohaven Ltd.
PHR / Phreesia, Inc.
STXS / Stereotaxis, Inc.
DVAX / Dynavax Technologies Corporation
UNH / UnitedHealth Group Incorporated
FGEN / FibroGen, Inc.
JAZZ / Jazz Pharmaceuticals plc
ANNX / Annexon, Inc.
PHAT / Phathom Pharmaceuticals, Inc.
INNV / InnovAge Holding Corp.
HMIN / Homeinns Hotel Group
CNC / Centene Corporation
GDRX / GoodRx Holdings, Inc.
ONEM / 1life Healthcare Inc
SGMO / Sangamo Therapeutics, Inc.
OLMA / Olema Pharmaceuticals, Inc.
PIRS / Pieris Pharmaceuticals, Inc.
TDOC / Teladoc Health, Inc.
HZNP / Horizon Therapeutics Plc
ABMD / Abiomed Inc.
EPIX / ESSA Pharma Inc.
GILD / Gilead Sciences, Inc.
EPZM / Epizyme Inc
COO / The Cooper Companies, Inc.
AERI / Aerie Pharmaceuticals Inc
VCRA / Vocera Communication Inc
RVNC / Revance Therapeutics, Inc.
HCAT / Health Catalyst, Inc.
EXAS / Exact Sciences Corporation
BMRN / BioMarin Pharmaceutical Inc.
XNCR / Xencor, Inc.
RCM / R1 RCM Inc.
HRMY / Harmony Biosciences Holdings, Inc.
OLK / Olink Holding AB (publ) - Depositary Receipt (Common Stock)
SGEN / Seagen Inc
VEEV / Veeva Systems Inc.
PGNY / Progyny, Inc.
GTHX / G1 Therapeutics, Inc.
GH / Guardant Health, Inc.
JNJ / Johnson & Johnson
AXNX / Axonics, Inc.
VRAY / ViewRay Inc.
RPID / Rapid Micro Biosystems, Inc.
MRTX / Mirati Therapeutics, Inc.
OSH / Oak Street Health Inc
MGNX / MacroGenics, Inc.
SAGE / Sage Therapeutics, Inc.
MCK / McKesson Corporation
RIGL / Rigel Pharmaceuticals, Inc.
MGTX / MeiraGTx Holdings plc
ISEE / IVERIC bio Inc
REGN / Regeneron Pharmaceuticals, Inc.
BIIB / Biogen Inc.
ALKS / Alkermes plc
HUM / Humana Inc.
APLS / Apellis Pharmaceuticals, Inc.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
CVS / CVS Health Corporation
DHR / Danaher Corporation
NBIX / Neurocrine Biosciences, Inc.
GKOS / Glaukos Corporation
PRVA / Privia Health Group, Inc.
NVCR / NovoCure Limited
NTLA / Intellia Therapeutics, Inc.
HCA / HCA Healthcare, Inc.
PFE / Pfizer Inc.
IMGN / ImmunoGen, Inc.
ISRG / Intuitive Surgical, Inc.
LLY / Eli Lilly and Company
MRK / Merck & Co., Inc.
BSX / Boston Scientific Corporation
CYTK / Cytokinetics, Incorporated
ITCI / Intra-Cellular Therapies, Inc.
ABBV / AbbVie Inc.
IONS / Ionis Pharmaceuticals, Inc.
TMO / Thermo Fisher Scientific Inc.
ESPR / Esperion Therapeutics, Inc.
THC / Tenet Healthcare Corporation
ALGN / Align Technology, Inc.
MDT / Medtronic plc
EW / Edwards Lifesciences Corporation
COR / Cencora, Inc.
ABT / Abbott Laboratories
CI / The Cigna Group
INSP / Inspire Medical Systems, Inc.
IOVA / Iovance Biotherapeutics, Inc.